U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Approval Year

Unknown
149124
Substance Class
Concept
Record UNII
Z2X598W2ZH
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
RNA (lymphocytic choriomeningitis virus vector HB-201 segment L), supramolecular complex with RNA (lymphocytic choriomeningitis virus vector HB-201 segment S-1 human papillomavirus 16 [24-glycine,26-glycine,91-glycine] gene E7 protein fusion protein with
Preferred Name English
r2LCMV-E7E6/immunogenic
Common Name English
r2LCMV-E7E6 (L-segment and the S-segment with LCMV NP and the mutant E7E6 fusion protein/immunogenic)
Common Name English
Code System Code Type Description
FDA UNII
Z2X598W2ZH
Created by admin on Wed Apr 02 17:36:17 GMT 2025 , Edited by admin on Wed Apr 02 17:36:17 GMT 2025
PRIMARY
This is a non-substance concept
Related Record Type Details
HUMAN PAPILLOMAVIRUS
TARGET ORGANISM->VACCINE ANTIGEN
Protein N (Lymphocytic choriomeningitis virus (strain Armstrong) (LCMV))
EXPRESSED PROTEIN->VECTOR
Esepapogene zalarnarepvec expressed RNA-directed RNA polymerase L
EXPRESSED PROTEIN->VECTOR
Related Record Type Details
r2LCMV-E7E6/immunogenic
ACTIVE MOIETY
This is a non-substance concept
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966